Related Experiment Videos
Single-session alcohol sclerotherapy in benign symptomatic hepatic cysts
T B Larssen1, A Viste, D K Jensen
1Department of Radiology, Haukeland University Hospital, Bergen, Norway.
Acta Radiologica (Stockholm, Sweden : 1987)
|December 12, 1997
Summary
Single-session alcohol sclerotherapy effectively reduced benign symptomatic liver cyst volumes in all patients. Temporary fluid re-accumulation occurred but resolved without repeat procedures, indicating a successful treatment.
Area of Science:
- Hepatology
- Interventional Radiology
- Gastroenterology
Background:
- Benign liver cysts can cause symptoms requiring intervention.
- Sclerotherapy offers a minimally invasive treatment option for symptomatic liver cysts.
Purpose of the Study:
- To assess the efficacy and outcomes of single-session alcohol sclerotherapy for benign symptomatic liver cysts.
Main Methods:
- Percutaneous catheterization was used to inject 96% ethanol into ten liver cysts (200-4,800 ml) in ten patients.
- Ethanol dosage was 10% of cyst volume, capped at 100 ml, with a maximum treatment time of 20 minutes.
Main Results:
- All patients achieved a satisfactory reduction in cyst volume post-treatment.
- Eight patients experienced temporary fluid re-accumulation, which subsequently resolved.
- No complications were reported besides transient pain.
Conclusions:
- Single-session alcohol sclerotherapy is a highly effective treatment for benign symptomatic liver cysts.
- The procedure led to significant cyst volume reduction in all cases.
- Temporary fluid re-accumulation did not necessitate repeat interventions.